Access to high-cost drugs: Decision makers' perspectives

UTSePress Research/Manakin Repository

Search UTSePress Research


Advanced Search

Browse

My Account

Show simple item record

dc.contributor.author Gallego, Gisselle en_US
dc.contributor.author Melocco, Terry en_US
dc.contributor.author Taylor, Susan en_US
dc.contributor.author Brien, Jo-Anne en_US
dc.contributor.editor en_US
dc.date.accessioned 2010-05-28T09:50:04Z
dc.date.available 2010-05-28T09:50:04Z
dc.date.issued 2005 en_US
dc.identifier 2007003477 en_US
dc.identifier.citation Gallego Gisselle et al. 2005, 'Access to high-cost drugs: Decision makers' perspectives', Society of Hospital Pharmacists of Australia, vol. 35, no. 1, pp. 18-20. en_US
dc.identifier.issn 1445-937X en_US
dc.identifier.other C1UNSUBMIT en_US
dc.identifier.uri http://hdl.handle.net/10453/9500
dc.description.abstract To explore the attitudes, perceptions and concerns among decision makers about equity of access to high-cost drugs in public hospitals. Method: 25 in-depth, semi-structured interviews were conducted with senior hospital administrators, directors of pharmacy and senior medical doctors. Topics included the decision-making process and associated problems, and solutions to issues of access to high-cost drugs. Interviews were audiotaped, transcribed verbatim and thematically analysed. Results: Healthcare funding models were perceived as obstacles to equity of access to high-cost drugs. Participants were concerned that there were inequities in decisions for individual patients according to public or private sector status. Tertiary public hospitals were seen to be at the 'cutting edge' and therefore were required to fund new and expensive drugs. This meant prioritising between patient groups and individuals. Participants had difficulty in identifying solutions. They suggested that ethical principles should be considered in addition to safety, efficacy and cost. Most wanted a transparent, accountable, evidence-based decision- making process. Conclusion: Decision makers were concerned about equity of access to high-cost drugs in public hospitals. They were also concerned about processes for decision making and the outcomes of these decisions. en_US
dc.language en_US
dc.publisher Society of Hospital Pharmacists of Australia en_US
dc.relation.isbasedon en_US
dc.rights Copyright Journal of Pharmacy Practice and Research and the Society of Hospital Pharmacists of Australia. en_US
dc.title Access to high-cost drugs: Decision makers' perspectives en_US
dc.parent Journal of Pharmacy Practice and Research en_US
dc.journal.volume 35 en_US
dc.journal.number 1 en_US
dc.publocation Australia en_US
dc.identifier.startpage 18 en_US
dc.identifier.endpage 20 en_US
dc.cauo.name BUS.Centre for Health Economics Research and Evaluation en_US
dc.conference Verified OK en_US
dc.for 111500 en_US
dc.personcode 102201 en_US
dc.personcode 0000045647 en_US
dc.personcode 0000033732 en_US
dc.personcode 0000033733 en_US
dc.percentage 100 en_US
dc.classification.name Pharmacology and Pharmaceutical Sciences en_US
dc.classification.type FOR-08 en_US
dc.edition en_US
dc.custom en_US
dc.date.activity en_US
dc.location.activity en_US
dc.description.keywords Attitude of Health Personnel; Decision Making, Organizational; Drug Costs; Hospitals, Public; Pharmaceutical Preparations, economics; Pharmaceutical Preparations, supply and distribution en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record